"Home grown companies should beef up manufacturing"- GS Chugh
29 May 2020 | Views
Gurmit Singh Chugh, Chairman, Translumina Therapeutics, New Delhi talks about the way forward post COVID-19
"Market access and quality control are crucial factors and are intertwined. Patients want the best quality of healthcare products, regardless of where they are manufactured, making it a watershed moment for homegrown med-tech and pharmaceutical companies to up the ante, and beef up manufacturing. The essence of a vibrant and self-reliant domestic healthcare delivery model is Indian companies making high quality and proven technologies and hospitals accepting and believing in their efforts rather than blindly accepting “imported” products.”
Gurmit Singh Chugh, Chairman, Translumina Therapeutics, New Delhi
